The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Role of Dose Potency in the Prediction of Risk of Myocardial Infarction Associated With Nonsteroidal Anti-Inflammatory Drugs in the General Population
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
Kearney, P. M., Baigent, C., Godwin, J., Halls, H., Emberson, J. R., & Patrono, C. (2006) · BMJ · doi:10.1136/bmj.332.7553.1302 · Cited by 1,445
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
Low-Dose Aspirin for the Prevention of Atherothrombosis
Patrono, C., García Rodríguez, L. A., Landolfi, R., & Baigent, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmra052717 · Cited by 1,218
Self-citationMcGettigan, P., & Henry, D. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60011 · Cited by 1,096
Grosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
Patrignani, P., Filabozzi, P., & Patrono, C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110576 · Cited by 937
Self-citationLow dose aspirin and inhibition of thromboxane B2 production in healthy subjects
Patrono, C., Ciabattoni, G., Pinca, E., Pugliese, F., Castrucci, G., De Salvo, A., Satta, M. A., & Peskar, B. A. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90066-3 · Cited by 651
Lewis, J. D., Schinnar, R., Bilker, W. B., Wang, X., & Strom, B. L. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1335 · Cited by 602
Patrignani, P., Panara, M. R., Greco, A., Fusco, O., Natoli, C., Iacobelli, S., Cipollone, F., Ganci, A., Créminon, C., & Maclouf, J. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24061-7 · Cited by 518
Self-citationLaneuville, O., Breuer, D. K., Dewitt, D. L., Hla, T., Funk, C. D., & Smith, W. L. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23861-7 · Cited by 472
Reilly, I., & FitzGerald, G. (1987) · Blood · doi:10.1182/blood.v69.1.180.180 · Cited by 419
Solomon, S. D., Wittes, J., Finn, P. V., Fowler, R., Viner, J., Bertagnolli, M. M., Arber, N., Levin, B., Meinert, C. L., Martin, B., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.764530 · Cited by 367
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects
Capone, M. L., Sciulli, M. G., Tacconelli, S., Grana, M., Ricciotti, E., Renda, G., Di Gregorio, P., Merciaro, G., & Patrignani, P. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.045 · Cited by 279
Self-citationOpposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II
Qi, Z., Hao, C., Langenbach, R. I., BREYER, R. M., Redha, R., Morrow, J. D., & Breyer, M. D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14752 · Cited by 249
Capone, M. L., Tacconelli, S., Sciulli, M. G., Grana, M., Ricciotti, E., Minuz, P., Di Gregorio, P., Merciaro, G., Patrono, C., & Patrignani, P. (2004) · Circulation · doi:10.1161/01.cir.0000124715.27937.78 · Cited by 229
Self-citationNonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General Population
García Rodríguez, L. A., Varas-Lorenzo, C., Maguire, A., & González-Pérez, A. (2004) · Circulation · doi:10.1161/01.cir.0000132491.96623.04 · Cited by 221
Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II
Qi, Z., Hao, C.-M., Langenbach, R. I., Breyer, R. M., Redha, R., Morrow, J. D., & Breyer, M. D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214752 · Cited by 210
Non‐Steroidal Antiinflammatory Drugs and the Risk of Acute Myocardial Infarction
Hernández‐Díaz, S., Varas‐Lorenzo, C., & García Rodríguez, L. A. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_302.x · Cited by 201
Self-citationPharmacodynamic of cyclooxygenase inhibitors in humans
Capone, M. L., Tacconelli, S., Di Francesco, L., Sacchetti, A., Sciulli, M. G., & Patrignani, P. (2007) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.05.019 · Cited by 190
Self-citationGarcía Rodríguez, L. A., Varas, C., & Patrono, C. (2000) · Epidemiology · doi:10.1097/00001648-200007000-00004 · Cited by 177
Self-citationPharmacokinetic–pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors
Huntjens, D. R. H., Danhof, M., & Pasqua, O. E. D. (2005) · Rheumatology · doi:10.1093/rheumatology/keh627 · Cited by 136
Arehart, E. J., Stitham, J., Asselbergs, F. W., Douville, K. L., MacKenzie, T. A., Fetalvero, K. M., Gleim, S., Kasza, Z., Rao, Y., Martel, L., et al. (2008) · Circulation Research · doi:10.1161/circresaha.107.165936 · Cited by 124
Renda, G., Tacconelli, S., Capone, M. L., Sacchetta, D., SANTARELLI, F., Sciulli, M. G., Zimarino, M., Grana, M., D’Amelio, E., & Zurro, M. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.05.004 · Cited by 117
Self-citationObservation and inference. An introduction to the methods of epidemiology
(1992) · Cancer Causes & Control · doi:10.1007/bf00051660 · Cited by 99
Mitchell, J. A., Lucas-Domínguez, R., Vojnovic, I., Hasan, K., Pepper, J., & Warner, T. D. (2006) · The FASEB Journal · doi:10.1096/fj.06-6615com · Cited by 82
Human Pharmacology of Naproxen Sodium
Capone, M. L., Tacconelli, S., Sciulli, M. G., Anzellotti, P., Francesco, L. D., Merciaro, G., Gregorio, P. D., & Patrignani, P. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.122283 · Cited by 82
Self-citationEtodolac Clinical Pharmacokinetics
Brocks, D. R., & Jamali, F. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199426040-00003 · Cited by 68
Minuz, P., Fumagalli, L., Gaino, S., Tommasoli, R., Degan, M., Cavallini, C., Lecchi, A., Cattaneo, M., Santonastaso, C. L., & Berton, G. (2006) · Biochemical Journal · doi:10.1042/bj20061015 · Cited by 38
The ever growing story of cyclo-oxygenase inhibition
Rodríguez, L. A. G., & Patrignani, P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69667-0 · Cited by 38
Self-citationImpact of Nonsteroidal Antiinflammatory Drugs on the Cardioprotective Effects of Aspirin
Corman, S. L., Fedutes, B. A., & Ansani, N. T. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e514 · Cited by 18
Cited by
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114147 · Cited by 1,920
Harirforoosh, S., Asghar, W., & Jamali, F. (2014) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3vw2f · Cited by 960
Use of NSAIDs in treating patients with arthritis
Crofford, L. J. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4174 · Cited by 650
Prostanoids in health and disease
Smyth, E. M., Grosser, T., Wang, M., Yu, Y., & FitzGerald, G. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800094-jlr200 · Cited by 543
Metadata
- Authors
- García Rodríguez, L. A., Tacconelli, S., & Patrignani, P.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2008-11
- Volume
- 52
- Issue
- 20
- Pages
- 1628-1636
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W1970351453
- Cited by
- 305
- References
- 34
- FWCI
- 12.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.